Profile data is unavailable for this security.
About the company
Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.
- Revenue in CHF (TTM)50.04bn
- Net income in CHF6.77bn
- LocationNovartis AGLichtstrasse 35BASEL 4056SwitzerlandCHE
- Phone+41 613241111
- Fax+41 613247826
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|NOVN:VTX since |
|Shire US Inc-Xiidra Assets||Deal completed||08 May 2019||08 May 2019Deal completed||3.63%||5.30bn|
|IFM Tre Inc||Deal completed||01 Apr 2019||01 Apr 2019Deal completed||-10.25%||1.58bn|
|CELLforCURE SASU||Deal completed||20 Dec 2018||20 Dec 2018Deal completed||1.61%||--|
|Endocyte Inc||Deal completed||18 Oct 2018||18 Oct 2018Deal completed||1.99%||2.09bn|